Grant AgreementAmyloidosis Foundation • April 11th, 2024
The primary purpose of The Amyloidosis Foundation (the ”AF”) in funding scientifically meritorious research is to advance its mission to eradicate Systemic Amyloidosis as a life-threatening disease. The policies are provided to assist applicants and grantees in understanding the terms and conditions that apply to each Grant. The full terms and conditions applicable to each Grant are set forth in this Grant Agreement, which incorporates these policies. By accepting an AF grant or fellowship, the Sponsoring Institution agrees to the terms and conditions of this Policy and accepts full responsibility for the conduct of the investigation and the acts of the investigator; project personnel, compensated in full or in part with funds awarded by the AF, are employees of the Sponsoring Institution; they are not AF employees. The Grant term is from January 1 – December 31, 2025.
